NeoChord raises $20 mln
NeoChord said Tuesday that it has closed an oversubscribed $20 million Series C financing round led by Deerfield Management. Baird Capital’s Venture Capital group participated as well as existing investors Hopen Life Science Ventures, CHV Capital, TGAP Ventures, and Heron Capital. Minnesota-based NeoChord is a medical technology company.
9 June 2015•3 mins read
